BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12762971)

  • 21. Type II Diabetes Mellitus and Endothelial Dysfunction: What Can We Do?
    Merdler I; Arbel Y
    Isr Med Assoc J; 2021 Feb; 23(2):121-122. PubMed ID: 33595219
    [No Abstract]   [Full Text] [Related]  

  • 22. Vascular endothelial dysfunction and nutritional compounds in early type 1 diabetes.
    Hoffman RP
    Curr Diabetes Rev; 2014 May; 10(3):201-7. PubMed ID: 24925525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of endothelial dysfunction in diabetes mellitus.
    Wascher TC; Graier WF; Bahadori B; Toplak H
    Circulation; 1994 Aug; 90(2):1109-10. PubMed ID: 8044928
    [No Abstract]   [Full Text] [Related]  

  • 24. Endothelial dysfunction and its role in diabetic vascular disease.
    Hartge MM; Kintscher U; Unger T
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):551-60, viii-ix. PubMed ID: 16959585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
    Palumbo PJ
    J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of endothelial progenitor cells in subjects with diabetes.
    Fadini GP; Sartore S; Agostini C; Avogaro A
    Diabetes Care; 2007 May; 30(5):1305-13. PubMed ID: 17277037
    [No Abstract]   [Full Text] [Related]  

  • 28. A new year's wish: "healthy endothelium".
    Gottlieb SH
    Diabetes Forecast; 2002 Jan; 55(1):105-7. PubMed ID: 14959663
    [No Abstract]   [Full Text] [Related]  

  • 29. Dyslipidaemia and cardiovascular risk in diabetes.
    Cullen P; von Eckardstein A; Souris S; Schulte H; Assmann G
    Diabetes Obes Metab; 1999 Jul; 1(4):189-98. PubMed ID: 11228753
    [No Abstract]   [Full Text] [Related]  

  • 30. From Endothelial Dysfunction to Arterial Stiffness in Diabetes Mellitus.
    Giraldo-Grueso M; Echeverri D
    Curr Diabetes Rev; 2020; 16(3):230-237. PubMed ID: 30332971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macro- and microvascular endothelial dysfunction in diabetes.
    Shi Y; Vanhoutte PM
    J Diabetes; 2017 May; 9(5):434-449. PubMed ID: 28044409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus.
    Woodman RJ; Watts GF
    Med Sci Monit; 2003 May; 9(5):RA81-9. PubMed ID: 12761466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood vessel wall interactions in diabetes.
    Schrör K
    Diabetes; 1997 Sep; 46 Suppl 2():S115-8. PubMed ID: 9285512
    [No Abstract]   [Full Text] [Related]  

  • 34. When to treat the hypertensive diabetic patient.
    Fuller JH
    J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modifications of structural and functional properties of large arteries in diabetes mellitus].
    Bortolotto LA
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):176-84. PubMed ID: 17505624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial stiffness, hypertension and diabetes mellitus.
    Cockcroft JR; Webb DJ; Wilkinson IB
    J Hum Hypertens; 2000 Jun; 14(6):377-80. PubMed ID: 10878698
    [No Abstract]   [Full Text] [Related]  

  • 37. [Physical activity and endothelial dysfunction in type 2 diabetic patients: the role of nitric oxide and oxidative stress].
    Brinkmann C; Schwinger RH; Brixius K
    Wien Med Wochenschr; 2011 Jun; 161(11-12):305-14. PubMed ID: 21360292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
    Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertension and diabetes mellitus].
    Janka HU
    Z Gesamte Inn Med; 1993 Mar; 48(3):157-61. PubMed ID: 8475640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arterial hypertension and diabetes mellitus].
    Charbonnel B; Mimran A
    Diabete Metab; 1992; 18(2 Pt 2):127-8. PubMed ID: 1639202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.